Do heparins do more than just treat thrombosis?: The influence of heparins on cancer spread

被引:181
作者
Hettiarachchi, RJK
Smorenburg, SM
Ginsberg, J
Levine, M
Prins, MH
Büller, HR
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Clin Oncol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands
[5] McMaster Univ, Hamilton Civ Hosp, Res Ctr, Hamilton, ON, Canada
[6] McMaster Univ, Hamilton Reg Canc Ctr, Hamilton, ON, Canada
关键词
D O I
10.1055/s-0037-1615937
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:947 / 952
页数:6
相关论文
共 33 条
[1]  
AGOSTINO D, 1961, J NATL CANCER I, V27, P17
[2]   TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM WITH LOW-MOLECULAR WEIGHT HEPARIN (FRAGMIN) - RESULTS OF A DOUBLE-BLIND RANDOMIZED STUDY [J].
ALBADA, J ;
NIEUWENHUIS, HK ;
SIXMA, JJ .
CIRCULATION, 1989, 80 (04) :935-940
[3]  
[Anonymous], TMN CLASSIFICATION M
[4]  
BRATT G, 1985, THROMB HAEMOSTASIS, V54, P813
[5]  
BRATT G, 1990, THROMB HAEMOSTASIS, V64, P506
[6]   A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis [J].
Decousus, H ;
Leizorovicz, A ;
Parent, F ;
Page, Y ;
Tardy, B ;
Girard, P ;
Laporte, S ;
Faivre, R ;
Charbonnier, B ;
Barral, FG ;
Huet, Y ;
Simonneau, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :409-415
[7]  
DUROUX P, 1991, THROMB HAEMOSTASIS, V65, P251
[8]  
Fiessinger JN, 1996, THROMB HAEMOSTASIS, V76, P195
[9]   LOWER MORTALITY IN CANCER-PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT VERSUS STANDARD HEPARIN [J].
GREEN, D ;
HULL, RD ;
BRANT, R ;
PINEO, GF .
LANCET, 1992, 339 (8807) :1476-1476
[10]   DOSE ADJUSTED HEPARIN TREATMENT OF DEEP VENOUS THROMBOSIS - A COMPARISON OF UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN [J].
HANDELAND, GF ;
ABILDGAARD, U ;
HOLM, HA ;
ARNESEN, KE .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 39 (02) :107-112